A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.


Updates from The Motley Fool

Latest updates on BioDelivery Sciences International from Fool.com.
Tomorrow's Monster Stock?

A list of promising companies chosen by investors who've already picked stocks that beat the mark...



Stock Performance

View Interactive BDSI Charts
Sponsored by

Key Data Points

Primary metrics and data points about BioDelivery Sciences International.
Current Price: $1.70
Prev Close: $1.70
Open: $1.70
Bid: $1.65
Ask: $1.80
Day's Range: $1.70 - $1.78
52wk Range: $1.50 - $3.78
Volume: 253,831
Avg Vol 434,199
Market Cap: $93M
P/E (ttm): -1.36
EPS (ttm): ($1.25)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BioDelivery Sciences International.
CAPS Rating 4 out of 5
 
203 Outperform
11 Underperform
CAPS All Stars
 
25 Outperform
4 Underperform

How do you think BioDelivery Sciences International will perform against the market?



You pick for BioDelivery Sciences International is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark A. Sirgo, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BioDelivery Sciences International.

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers